Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Pain Management Market

Veterinary Pain Management Market Share

Report ID: GMI5882
Published Date: May 2023
Report Format: PDF

Download Free Sample

Veterinary Pain Management Market Share

The key veterinary pain management market players include

Boehringer Ingelheim International GmbH
Zoetis Inc.
Merck & Co., Inc.
Elanco Animal Health Incorporated
Norbrook
Ceva Santé Animale
Dechra Pharmaceuticals
Vetoquinol Inc
Alivira Animal Health Limited
Chanelle Pharma
K-Laser USA
Multi Radiance Medical

Market players adopt and implement various strategies, such as product launches, collaborations, expansions, and mergers. For instance, in October 2021, Summus Laser introduced “Horizon Veterinary Laser System,’’ a Class IV laser therapy system designed specifically for veterinary pain management. It is a diode-based laser with 28-watt power and has the unique capability of combining four different wavelengths, which can be controlled independently as well.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary pain management industry size was USD 1.7 billion in 2023 and will witness 7.1% CAGR from 2024-2032 driven by the rising number of pet owners worldwide.

The drug product segment is expected to gain traction through 2032 owing to their rising usage to treat a wide variety of diseases

The veterinary hospitals end-user segment held 43.8% of the veterinary pain management industry share in 2022 due to the ease of access to professional therapies.

Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Norbrook, Ceva Santé Animale, Dechra Pharmaceuticals, Vetoquinol Inc., Alivira Animal Health Limited are some of the key veterinary pain management market players